Subscribe Now Subscribe Now
Home > Mumbai > Mumbai News > Article > New Omicron variants not causing significant rise in hospitalisations Experts

New Omicron variants not causing significant rise in hospitalisations: Experts

Updated on: 03 November,2022 10:52 AM IST  |  Mumbai

The symptoms caused by these strains of the virus are mild

New Omicron variants not causing significant rise in hospitalisations: Experts

Representative image

The new variants of Omicron, XXB and BQ.1, have not led to any significant rise in coronavirus infections and hospitalisations in Maharashtra, experts have said.

The symptoms caused by these strains of the virus are mild, they noted.

Dr Anita Mathew, Infectious Disease Specialist at Fortis Hospital, Mulund, said many of the new patients are asymptomatic.

"Many people have incidental COVID-19. In other words, they are visiting the hospital for other health conditions and test positive for the coronavirus infection," she told PTI.

Also read: Bureaucrats summoned on complaint over 'discriminatory' Covid-19 restrictions

Symptoms such as the loss of smell and taste, observed prominently in earlier infections, have not been noticed in many patients. Many of them report cold and cough, which is why there isn't a lot of testing or self-isolation, Dr Mathew added.

She, however, stressed that vaccination against coronavirus was still important.

"One should be careful so that the risk of infecting others decreases," she said.

As per the state health department, 17 per cent more COVID-19 cases were recorded during October 10 to 16 against the preceding week (October 3-9). The rise was noticed mainly in Thane, Raigad and Mumbai, all densely-populated districts.

The department had also cautioned that coronavirus cases could rise during winter and the festive season, citing new variants which have greater immune evasive ability.

Dr Vasanthapuram Ravi, Virologist, Head, R&D, TATA Medical and Diagnostics (and Chairman of Karnataka Genomic Surveillance Committee) said the new strain of virus and the disease genotype were no different from Omicron in terms of severity and asymptomatic status.

"It is a hybrid of two Omicron variants, 3.75 and BJ1, due to which it has a novel mutation in the spike proteins which makes it escape the antibodies generated by vaccines. This is why it is causing infections even in vaccinated people," he said.

But there is not much to worry due to its lessened severity though testing is still important, he added.

If a patient tests positive for Omicron, he or she can get treatment for Omicron infection, Dr Ravi said.

But if the test is negative for Omicron (despite symptoms) then one needs to immediately consult a physician in case there is a presence of a new variant or another virus like flu virus or RSV (respiratory syncytial virus), he added.

The Indian SARS-CoV-2 Genomics Consortium (INSACOG), in a statement, said it was keeping a close watch on the emergence and evolution of XBB and XBB.1 and any new sub-lineages.

But Indian patients infected with Omicron sub-lineage XBB of COVID-19 have mild disease, it went on to add.

Dr Laxman Jessani, Consultant, Infectious Diseases at Apollo hospitals in Navi Mumbai, said the chances of hospitalisation and ICU admissions are low as the infections are mostly mild.

He too said that there was no significant rise in cases in the last few weeks.

"High-risk groups and elderly people should avoid going out to prevent getting infected, especially in crowded places," he said, adding that wearing a mask is a must.

This story has been sourced from a third party syndicated feed, agencies. Mid-day accepts no responsibility or liability for its dependability, trustworthiness, reliability and data of the text. Mid-day management/ reserves the sole right to alter, delete or remove (without notice) the content in its absolute discretion for any reason whatsoever.

"Exciting news! Mid-day is now on WhatsApp Channels Subscribe today by clicking the link and stay updated with the latest news!" Click here!

Register for FREE
to continue reading !

This is not a paywall.
However, your registration helps us understand your preferences better and enables us to provide insightful and credible journalism for all our readers.

Mid-Day Web Stories

Mid-Day Web Stories

This website uses cookie or similar technologies, to enhance your browsing experience and provide personalised recommendations. By continuing to use our website, you agree to our Privacy Policy and Cookie Policy. OK